Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Subscriber Content

MediStem and Superview to Develop Antibodies that Affect Stem Cells

publication date: Oct 1, 2012

MediStem of San Diego formed a stem cell collaboration with Superview Biotechnology Co., a subsidiary of Yinhuan Holding. The two companies will use MediStem’s proprietary stem cell lines to screen monoclonal antibodies. Their goal will be to assess whether antibodies can modulate the activity of stem cells that already exist in the body. The companies will evaluate various candidates jointly, as well as apply for grants and share research data. More details....

Stock Symbol: (Pink Sheets: MEDS)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.If you're not a subscriber why not subscribe today?